What is AptameX?
AptameX is an innovative rapid test that uses DNA aptamers instead of antigens to detect the SARS-CoV-2 virus. By using aptamer technology, we have been able to design a friendlier and better customer experience that achieves higher degrees of accuracy than nearly all other rapid tests and at a lower cost to the end consumer. AptameX received product and registration approval from Indonesia’s Ministry of Health in mid-2021 and received the CE Mark in the European Union in May 2022.
As we move beyond the acute phase of the pandemic amidst the slow rate of vaccination in developing countries, the combination of ultra-low cost, highly accurate testing and rising availability of therapeutics may present an option to alleviate the effects of Covid-19 for the vast majority of people so that everyone can continue with their daily lives.
How does it work?
Our Covid-19 rapid test is in the form of a user-friendly, saliva-based rapid test. First, a user rinses their mouth with a standard non-alcoholic dental mouthwash, followed by purified water. The user then spits into a sample collection tube which is then processed by a lab. The sample is diluted in water and added to a cuvette containing reagent. After 10 minutes, a salt quench is added and after one minute, the sample is ready to be scanned by a standard UV-spectrophotometer.
What sets AptameX apart from other rapid tests is its differentiated chemistry. Aptamers are single-stranded DNA or RNA oligonucleotides that bind to specific targets via shape recognition with high affinity and specificity. As aptamers are synthetic, they can be produced at a low cost and in scale.
For more information, see our FAQ.
What does the future hold?
We believe there are three key parts to our business.
As the world learns to live with Covid-19, a more practical and user-friendly approach to testing is needed and the experience will move from a negative model of test and quarantine to test and grab a therapeutic.
The rapid test is separated into the sampling and software, plus the spectrophotometer. Future iterations may be packaged with other approved spectrophotometers to provide a more convenient solution.
The pandemic has accelerated a shift to new technologies in healthcare delivery from the revolution in vaccines to telehealth. We believe aptamers can revolutionise healthcare through… and are evaluating a range of other diagnostics for other applications.